These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35403535)

  • 1. Combination of mifepristone and misoprostol vs misoprostol monotherapy for treatment of second-trimester pregnancy loss.
    Valero I; Garcia-Jimenez R; Weber-Fernandez AM; Diaz-Acedo R; Fobelo-Lozano MJ; Cerrillos L; Ostos R
    Eur J Contracept Reprod Health Care; 2022 Aug; 27(4):341-344. PubMed ID: 35403535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mifepristone and misoprostol is safe and effective method in the second-trimester pregnancy termination.
    Nissi R; Santala M; Immonen E; Talvensaari-Mattila A
    Arch Gynecol Obstet; 2016 Nov; 294(6):1243-1247. PubMed ID: 27522599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mifepristone-Misoprostol Use for Second- and Third-Trimester Medical Termination of Pregnancy in a Canadian Tertiary Care Centre.
    Vlad S; Boucoiran I; St-Pierre ÉR; Ferreira E
    J Obstet Gynaecol Can; 2022 Jun; 44(6):683-689. PubMed ID: 35114381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mifepristone followed by misoprostol or oxytocin for second-trimester abortion: a randomized controlled trial.
    Elami-Suzin M; Freeman MD; Porat N; Rojansky N; Laufer N; Ben-Meir A
    Obstet Gynecol; 2013 Oct; 122(4):815-820. PubMed ID: 24084539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mifepristone and Misoprostol vs Misoprostol Alone in Second Trimester Termination of Pregnancy.
    Shah D; Rijal P; Thakur A; Rai R
    JNMA J Nepal Med Assoc; 2018; 56(213):856-860. PubMed ID: 31065120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of shorter mifepristone to misoprostol intervals for second trimester medical abortion: a retrospective cohort study.
    Henkel A; Lerma K; Blumenthal PD; Shaw KA
    Contraception; 2020 Nov; 102(5):327-331. PubMed ID: 32592800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy.
    Dabash R; Chelli H; Hajri S; Shochet T; Raghavan S; Winikoff B
    Int J Gynaecol Obstet; 2015 Jul; 130(1):40-4. PubMed ID: 25896965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy.
    Bartley J; Baird DT
    BJOG; 2002 Nov; 109(11):1290-4. PubMed ID: 12452468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy.
    Ngai SW; Tang OS; Ho PC
    Hum Reprod; 2000 Oct; 15(10):2205-8. PubMed ID: 11006200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on second trimester medical abortion.
    Lerma K; Shaw KA
    Curr Opin Obstet Gynecol; 2017 Dec; 29(6):413-418. PubMed ID: 28922193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Termination of 2nd and 3rd trimester pregnancies with mifepristone and misoprostol.
    Jannet D; Aflak N; Abankwa A; Carbonne B; Marpeau L; Milliez J
    Eur J Obstet Gynecol Reprod Biol; 1996 Dec; 70(2):159-63. PubMed ID: 9119097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
    Verhulsdonk MT; Papatsonis DN; Heydanus R
    Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Labour induction for termination of pregnancy with severe fetal anomalies after 24 weeks' gestation: a case series and systematic review of the literature.
    Kiley J; Turner A; Nosal C; Beestrum M; Dungan J
    Eur J Contracept Reprod Health Care; 2022 Dec; 27(6):486-493. PubMed ID: 35899830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mifepristone and oral, vaginal, or sublingual misoprostol for second-trimester abortion: a randomized controlled trial.
    Dickinson JE; Jennings BG; Doherty DA
    Obstet Gynecol; 2014 Jun; 123(6):1162-1168. PubMed ID: 24807339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review.
    Abubeker FA; Lavelanet A; Rodriguez MI; Kim C
    BMC Womens Health; 2020 Jul; 20(1):142. PubMed ID: 32635921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.
    Gemzell-Danielsson K; Lalitkumar S
    Reprod Health Matters; 2008 May; 16(31 Suppl):162-72. PubMed ID: 18772097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Termination of second-trimester pregnancy by mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate (Rivanol®): a systematic review of Chinese trials.
    Hou SP; Fang AH; Chen QF; Huang YM; Chen OJ; Cheng LN
    Contraception; 2011 Sep; 84(3):214-23. PubMed ID: 21843683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Same-day mifepristone prior to second-trimester induction termination with misoprostol: A retrospective cohort study.
    Shay RL; Benson LS; Lokken EM; Micks EA
    Contraception; 2022 Mar; 107():29-35. PubMed ID: 34529952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion.
    Chai J; Tang OS; Hong QQ; Chen QF; Cheng LN; Ng E; Ho PC
    Hum Reprod; 2009 Feb; 24(2):320-4. PubMed ID: 19049993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcomes and Women's Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa.
    Constant D; Harries J; Malaba T; Myer L; Patel M; Petro G; Grossman D
    PLoS One; 2016; 11(9):e0161843. PubMed ID: 27583448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.